Metabolically Healthy, but Obese Individuals and Associations with Echocardiographic Parameters and Inflammatory Biomarkers: Results from the CARLA Study

References

• Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes. 2011;35(7):971–981. doi:10.1038/ijo.2010.216
   PubMed Web of Science ®Google Scholar
• Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab. 2004;30(6):569–572. doi:10.1016/S1262-3636(07)70156-8
   PubMed Web of Science ®Google Scholar
• Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Prevalence of uncomplicated obesity in an Italian obese population. Obes Res. 2005;13(6):1116–1122. doi:10.1038/oby.2005.130
   PubMedGoogle Scholar
• Korduner J, Bachus E, Jujic A, Magnusson M, Nilsson PM. Metabolically healthy obesity (MHO) in the Malmo diet cancer study – epidemiology and prospective risks. Obes Res Clin Pract. 2019;13(6):548–554. doi:10.1016/j.orcp.2019.10.002
   PubMedGoogle Scholar
• Al-Khalidi B, Kimball SM, Kuk JL, Ardern CI. Metabolically healthy obesity, vitamin D, and all-cause and cardiometabolic mortality risk in NHANES III. Clin Nutr. 2019;38(2):820–828. doi:10.1016/j.clnu.2018.02.025
   PubMedGoogle Scholar
• Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism. 2001;50(12):1499–1504. doi:10.1053/meta.2001.27213
   PubMed Web of Science ®Google Scholar
• Bluher M. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol. 2010;21(1):38–43. doi:10.1097/MOL.0b013e3283346ccc
   PubMed Web of Science ®Google Scholar
• Wang YC, Liang CS, Gopal DM, et al. Preclinical systolic and diastolic dysfunctions in metabolically healthy and unhealthy obese individuals. Circ Heart Fail. 2015;8(5):897–904. doi:10.1161/CIRCHEARTFAILURE.114.002026
   PubMedGoogle Scholar
• Park J, Kim SH, Cho GY, et al. Obesity phenotype and cardiovascular changes. J Hypertens. 2011;29(9):1765–1772. doi:10.1097/HJH.0b013e32834a50f3
   PubMed Web of Science ®Google Scholar
• Dobson R, Burgess MI, Sprung VS, et al. Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. Int J Obes. 2016;40(1):153–161. doi:10.1038/ijo.2015.151
   PubMed Web of Science ®Google Scholar
• Hamer M, Bell JA, Sabia S, Batty GD, Kivimaki M. Stability of metabolically healthy obesity over 8 years: the English longitudinal study of ageing. Eur J Endocrinol. 2015;173(5):703–708. doi:10.1530/EJE-15-0449
   PubMed Web of Science ®Google Scholar
• Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham heart study. Circulation. 2007;116(11):1234–1241. doi:10.1161/CIRCULATIONAHA.107.710509
   PubMed Web of Science ®Google Scholar
• Ortega FJ, Fernandez-Real JM. Inflammation in adipose tissue and fatty acid anabolism: when enough is enough! Hormon Metab Res. 2013;45(13):1009–1019. doi:10.1055/s-0033-1358690
   PubMedGoogle Scholar
• Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020;7:22.
   PubMed Web of Science ®Google Scholar
• Iglesias Molli AE, Penas Steinhardt A, Lopez AP, et al. Metabolically healthy obese individuals present similar chronic inflammation level but less insulin-resistance than obese individuals with metabolic syndrome. PLoS One. 2017;12(12):e0190528. doi:10.1371/journal.pone.0190528
   PubMed Web of Science ®Google Scholar
• Alam I, Ng TP, Larbi A. Does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspective. Mediators Inflamm. 2012;2012:456456. doi:10.1155/2012/456456
   PubMedGoogle Scholar
• Greiser KH, Kluttig A, Schumann B, et al. Cardiovascular disease, risk factors and heart rate variability in the elderly general population: design and objectives of the CARdiovascular disease, living and ageing in Halle (CARLA) study. BMC Cardiovasc Disord. 2005;5:33. doi:10.1186/1471-2261-5-33
   PubMedGoogle Scholar
• Greiser KH, Kluttig A, Schumann B, et al. Cardiovascular diseases, risk factors and short-term heart rate variability in an elderly general population: the CARLA study 2002–2006. Eur J Epidemiol. 2009;24(3):123–142. doi:10.1007/s10654-009-9317-z
   PubMedGoogle Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Gottdiener JS, Bednarz J, Devereux R, et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr. 2004;17(10):1086–1119. doi:10.1016/j.echo.2004.07.013
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440–1463. doi:10.1016/j.echo.2005.10.005
   PubMed Web of Science ®Google Scholar
• Chirinos JA, Segers P, De Buyzere ML, et al. Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension. 2010;56(1):91–98. doi:10.1161/HYPERTENSIONAHA.110.150250
   PubMedGoogle Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644
   PubMed Web of Science ®Google Scholar
• Demirtas H, Freels SA, Yucel RM. Plausibility of multivariate normality assumption when multiply imputing non-Gaussian continuous outcomes: a simulation assessment. J Stat Comput Simul. 2008;78(1):69–84. doi:10.1080/10629360600903866
   Web of Science ®Google Scholar
• Bodner TE. What improves with increased missing data imputations? Struct Equ Modeling. 2008;15(4):651–675. doi:10.1080/10705510802339072
   Web of Science ®Google Scholar
• Liao Y, Cooper RS, Mensah GA, McGee DL. Left ventricular hypertrophy has a greater impact on survival in women than in men. Circulation. 1995;92(4):805–810. doi:10.1161/01.CIR.92.4.805
   PubMed Web of Science ®Google Scholar
• Morkedal B, Vatten LJ, Romundstad PR, Laugsand LE, Janszky I. Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trondelag Health Study), Norway. J Am Coll Cardiol. 2014;63(11):1071–1078. doi:10.1016/j.jacc.2013.11.035
   PubMed Web of Science ®Google Scholar
• Mathew H, Farr OM, Mantzoros CS. Metabolic health and weight: understanding metabolically unhealthy normal weight or metabolically healthy obese patients. Metabolism. 2016;65(1):73–80. doi:10.1016/j.metabol.2015.10.019
   PubMed Web of Science ®Google Scholar
• Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796–1808. doi:10.1172/JCI200319246
   PubMed Web of Science ®Google Scholar
• Altintas MM, Azad A, Nayer B, et al. Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res. 2011;52(3):480–488. doi:10.1194/jlr.M011338
   PubMed Web of Science ®Google Scholar
• Loos RJF, Kilpelainen TO. Genes that make you fat, but keep you healthy. J Intern Med. 2018;284(5):450–463. doi:10.1111/joim.12827
   PubMedGoogle Scholar
• Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract. 2005;69(1):29–35. doi:10.1016/j.diabres.2004.11.007
   PubMed Web of Science ®Google Scholar
• Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev. 1996;7(3):231–240. doi:10.1016/S1359-6101(96)00026-3
   PubMedGoogle Scholar
• Appleton SL, Seaborn CJ, Visvanathan R, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013;36(8):2388–2394. doi:10.2337/dc12-1971
   PubMed Web of Science ®Google Scholar
• Schaffler A, Scholmerich J. Innate immunity and adipose tissue biology. Trends Immunol. 2010;31(6):228–235. doi:10.1016/j.it.2010.03.001
   PubMed Web of Science ®Google Scholar
• Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116(11):3015–3025. doi:10.1172/JCI28898
   PubMed Web of Science ®Google Scholar
• Masiha S, Sundstrom J, Lind L. Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women. J Hum Hypertens. 2013;27(1):13–17. doi:10.1038/jhh.2011.113
   PubMed Web of Science ®Google Scholar
• Dinh W, Futh R, Nickl W, et al. Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc Diabetol. 2009;8:58. doi:10.1186/1475-2840-8-58
   PubMed Web of Science ®Google Scholar
• Bozkurt B, Kribbs SB, Clubb FJ, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation. 1998;97(14):1382–1391. doi:10.1161/01.CIR.97.14.1382
   PubMed Web of Science ®Google Scholar
• Hamid T, Xu Y, Ismahil MA, et al. TNF receptor signaling inhibits cardiomyogenic differentiation of cardiac stem cells and promotes a neuroadrenergic-like fate. Am J Physiol Heart Circ Physiol. 2016;311(5):H1189–H1201. doi:10.1152/ajpheart.00904.2015
   PubMedGoogle Scholar
• Brun P, Castagliuolo I, Di Leo V, et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2007;292(2):G518–525. doi:10.1152/ajpgi.00024.2006
   PubMed Web of Science ®Google Scholar
• Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, Lee JH. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes. 2006;30(10):1529–1534. doi:10.1038/sj.ijo.0803304
   PubMed Web of Science ®Google Scholar
• Echouffo-Tcheugui JB, Short MI, Xanthakis V, et al. Natural history of obesity subphenotypes: dynamic changes over two decades and prognosis in the Framingham heart study. J Clin Endocrinol Metab. 2019;104(3):738–752. doi:10.1210/jc.2018-01321
   PubMed Web of Science ®Google Scholar
• Espinosa De Ycaza AE, Donegan D, Jensen MD. Long-term metabolic risk for the metabolically healthy overweight/obese phenotype. Int J Obes. 2018;42(3):302–309. doi:10.1038/ijo.2017.233
   Google Scholar
• Mongraw-Chaffin M, Foster MC, Anderson CAM, et al. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2018;71(17):1857–1865. doi:10.1016/j.jacc.2018.02.055
   PubMed Web of Science ®Google Scholar
• Kouvari M, Panagiotakos DB, Yannakoulia M, et al. Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: the ATTICA cohort study. Metabolism. 2019;93:18–24. doi:10.1016/j.metabol.2019.01.003
   PubMed Web of Science ®Google Scholar
• Hamer M, Ingle L, Carroll S, Stamatakis E. Physical activity and cardiovascular mortality risk: possible protective mechanisms? Med Sci Sports Exerc. 2012;44(1):84–88. doi:10.1249/MSS.0b013e3182251077
   PubMedGoogle Scholar
• Poelkens F, Eijsvogels TM, Brussee P, Verheggen RJ, Tack CJ, Hopman MT. Physical fitness can partly explain the metabolically healthy obese phenotype in women. Exp Clin Endocrinol Diabetes. 2014;122(2):87–91. doi:10.1055/s-0033-1363686
   PubMed Web of Science ®Google Scholar
• Ingle L, Swainson M, Brodie D, Sandercock GR. Characterization of the metabolically healthy phenotype in overweight and obese British men. Prev Med. 2017;94:7–11. doi:10.1016/j.ypmed.2016.11.001
   PubMedGoogle Scholar
• Roberson LL, Aneni EC, Maziak W, et al. Beyond BMI: the “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality – a systematic review. BMC Public Health. 2014;14:14. doi:10.1186/1471-2458-14-14
   PubMed Web of Science ®Google Scholar
• Koves TR, Li P, An J, et al. Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem. 2005;280(39):33588–33598. doi:10.1074/jbc.M507621200
   PubMed Web of Science ®Google Scholar
• Schousboe JT, Langsetmo L, Schwartz AV, et al. Comparison of associations of DXA and CT visceral adipose tissue measures with insulin resistance, lipid levels, and inflammatory markers. J Clin Densitometr. 2017;20(2):256–264. doi:10.1016/j.jocd.2017.01.004
   PubMedGoogle Scholar